Illumina Owes BGI $333.8 Million Over Gene-Sequencer Patents (2)

Illumina Inc. owes BGI Group, the world’s largest maker of commercial genetic sequencers, $333.8 million after a federal jury in Delaware found Friday that some of its DNA sequencing systems infringe two patents related to technology that deduces each nucleotide’s identity from two signals.

The jury, which started deliberating Thursday afternoon, also found that sequencers sold by BGI’s Complete Genomics Inc. infringe two of three Illumina patents, but it said all three shouldn’t have been issued in the first place, mooting any potential award, according to the verdict issued in the U.S. District Court for the District of Delaware.

The ...